Adare Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Adare has been transforming oral delivery challenges into proprietary product solutions.
One of their notable products is AR17 -APT5037 IR ORALLY DISINTEGRATING TABLETS, with a corresponding US DMF Number 29453.
Remarkably, this DMF maintains an Active status since its submission on June 16, 2015, highlighting commitment to regulatory compliance.